Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$640M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$501M |
| 3 |
Digital Realty Trust
DLR
|
+$438M |
| 4 |
Intuitive Surgical
ISRG
|
+$437M |
| 5 |
Amazon
AMZN
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$545M |
| 2 |
DexCom
DXCM
|
+$457M |
| 3 |
AT&T
T
|
+$431M |
| 4 |
Palo Alto Networks
PANW
|
+$416M |
| 5 |
Humana
HUM
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.03% |
| 2 | Healthcare | 2.92% |
| 3 | Consumer Discretionary | 1.99% |
| 4 | Financials | 1.93% |
| 5 | Industrials | 1.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMS
6951
PUT
DELISTED
GMS Inc
GMS
| $761K | ﹤0.01% |
11,000
+9,300
| +547% | +$575K |
|
6952
CALL
Addus HomeCare
ADUS
$2.21B
| $760K | ﹤0.01% |
8,200
-10,900
| -57% | -$1.04M |
|
6953
PUT
Arcturus Therapeutics
ARCT
$233M
| $760K | ﹤0.01% |
26,500
+7,200
| +37% | +$196K |
|
|
AUROW
6954
Aurora Innovation Warrant
AUROW
$211M
| $759K | ﹤0.01% |
1,650,835
-1,144
| -0.1% | -$274 |
|
|
TVRD
6955
Tvardi Therapeutics
TVRD
$25.3M
| $759K | ﹤0.01% |
7,452
-5,953
| -44% | -$820K |
|
6956
Northwest Bancshares
NWBI
$2.29B
| $758K | ﹤0.01% |
71,550
-232,474
| -76% | -$2.58M |
|
6957
Takeda Pharmaceutical
TAK
$57.6B
| $758K | ﹤0.01% |
48,275
-7,741
| -14% | -$127K |
|
6958
CALL
Scholastic
SCHL
$779M
| $758K | ﹤0.01% |
19,500
+12,100
| +164% | +$470K |
|
|
TWOU
6959
DELISTED
2U Inc
TWOU
| $758K | ﹤0.01% |
6,272
-33,742
| -84% | -$4.49M |
|
6960
CALL
ImmunityBio
IBRX
$8.18B
| $758K | ﹤0.01% |
272,700
+6,500
| +2% | +$18.4K |
|
6961
Praxis Precision Medicines
PRAX
$10.3B
| $758K | ﹤0.01% |
43,947
+2,361
| +6% | +$36.1K |
|
|
BLUE
6962
PUT
DELISTED
bluebird bio
BLUE
| $758K | ﹤0.01% |
11,520
+1,565
| +16% | +$114K |
|
6963
iShares Core S&P US Growth ETF
IUSG
$33.4B
| $758K | ﹤0.01% |
7,763
-10,595
| -58% | -$972K |
|
|
CVAC
6964
CALL
DELISTED
CureVac
CVAC
| $758K | ﹤0.01% |
72,700
-5,500
| -7% | -$49.2K |
|
6965
iShares Floating Rate Bond ETF
FLOT
$10.6B
| $755K | ﹤0.01% |
14,854
-53,236
| -78% | -$2.69M |
|
6966
PUT
PROG Holdings
PRG
$1.65B
| $755K | ﹤0.01% |
23,500
-9,400
| -29% | -$283K |
|
6967
PUT
Ameresco
AMRC
$1.35B
| $754K | ﹤0.01% |
15,500
+200
| +1% | +$9.01K |
|
6968
JPMorgan Short Duration Core Plus ETF
JSCP
$1.78B
| $753K | ﹤0.01% |
16,447
+5,735
| +54% | +$264K |
|
6969
PUT
Burford Capital
BUR
$909M
| $753K | ﹤0.01% |
61,800
+39,500
| +177% | +$511K |
|
6970
FB Financial Corp
FBK
$3.05B
| $752K | ﹤0.01% |
26,827
+18,886
| +238% | +$538K |
|
6971
ClearPoint Neuro
CLPT
$463M
| $752K | ﹤0.01% |
103,914
+29,976
| +41% | +$255K |
|
6972
PUT
Ingredion
INGR
$6.65B
| $752K | ﹤0.01% |
7,100
-12,100
| -63% | -$1.29M |
|
6973
CALL
Eastern Bankshares
EBC
$5.4B
| $752K | ﹤0.01% |
61,300
-15,500
| -20% | -$184K |
|
|
BELFB
6974
CALL
Bel Fuse Inc Class B
BELFB
$3.98B
| $752K | ﹤0.01% |
13,100
+8,600
| +191% | +$394K |
|
|
EH
6975
EHang Holdings
EH
$430M
| $752K | ﹤0.01% |
+49,541
| New | +$574K |
|
Similar funds
Ken Griffin's Q2 2023 Portfolio in Review
As of Q2 2023, Ken Griffin held 15,826 positions worth $484B, up 6.4% from $455B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Ken Griffin withdrew a net $16.6B in Q2 2023, closing 1,562 positions and reducing 7,223 holdings. Its most notable exit was State Street Industrial Select Sector SPDR ETF, an estimated $192M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in BILL Holdings worth $222M.
- Ken Griffin's largest Q2 2023 buy was BILL Holdings: 1,901,064 shares worth $222M.
- Ken Griffin added most to Microsoft in Q2 2023, an estimated $640M increase.
- Ken Griffin's biggest Q2 2023 reduction was NVIDIA, cutting an estimated $545M.
- Ken Griffin fully exited State Street Industrial Select Sector SPDR ETF in Q2 2023, selling an estimated $192M.
- Ken Griffin's ten largest holdings make up 36% of its $484B portfolio in Q2 2023.
- Ken Griffin opened 1,205 new positions and closed 1,562 in Q2 2023.
- Ken Griffin's portfolio value rose 6.4% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.